Ardent Health (ARDT) Projected to Post Quarterly Earnings on Wednesday

Ardent Health (NYSE:ARDT) is expected to be posting its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.35 per share for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, March 5, 2026 at 10:00 AM ET.

Ardent Health Price Performance

Shares of ARDT stock opened at $9.80 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.08 and a quick ratio of 1.95. The company has a market capitalization of $1.40 billion, a P/E ratio of 6.76, a P/E/G ratio of 5.56 and a beta of 0.72. The company’s 50-day simple moving average is $8.84 and its two-hundred day simple moving average is $11.20. Ardent Health has a one year low of $8.07 and a one year high of $15.59.

Institutional Trading of Ardent Health

A number of institutional investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its stake in Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after purchasing an additional 2,638 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Ardent Health in the third quarter valued at approximately $61,000. New York State Common Retirement Fund lifted its position in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after buying an additional 3,400 shares in the last quarter. Squarepoint Ops LLC acquired a new position in Ardent Health during the third quarter worth $145,000. Finally, Fox Run Management L.L.C. purchased a new stake in Ardent Health in the 4th quarter valued at $147,000.

More Ardent Health News

Here are the key news stories impacting Ardent Health this week:

• Neutral Sentiment: Multiple national plaintiff firms are actively soliciting Ardent investors and reminding holders of the March 9, 2026 lead‑plaintiff deadline — a procedural development that increases class‑action activity but does not itself create new allegations. ROSEN: ARDT Final Deadline
• Negative Sentiment: Allegations of undisclosed collections problems and related securities‑fraud claims have been publicized by several firms; one complaint ties prior company statements to a sharp (~33%) stock decline and seeks lead plaintiffs for a federal action pending in the Middle District of Tennessee — this increases litigation and reputational risk for ARDT. KSF: Securities Fraud Class Action
• Negative Sentiment: Hagens Berman and other firms highlight an alleged “$97M accounting shock” and the company’s prior use of a rigid “180‑day cliff” to reserve uncollectible accounts — if true, this could imply material prior misstatements, greater reserve volatility, or future restatements that would materially affect earnings and leverage. Hagens Berman: $97M Accounting Shock

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ARDT shares. Leerink Partners set a $16.00 target price on Ardent Health in a report on Friday, November 14th. Stephens cut their price target on shares of Ardent Health from $21.00 to $17.00 and set an “overweight” rating on the stock in a report on Friday, November 14th. Morgan Stanley restated an “equal weight” rating and set a $12.00 price objective (down previously from $22.00) on shares of Ardent Health in a report on Friday, November 14th. Weiss Ratings restated a “sell (d)” rating on shares of Ardent Health in a research note on Monday, December 29th. Finally, Truist Financial reduced their price target on shares of Ardent Health from $21.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, November 14th. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $14.58.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.